Biotechnology
Diffusion Pharmaceuticals Presents TSC Candidate at Biotech Conference, Stock Climbs 35%
Diffusion Pharmaceuticals Inc. (NASDAQCM:DFFN) has experienced a stock increase of 35% today on the Nasdaq Capital Market. At the time of writing, the stock has moved $0.43, from the previous closing price of $1.21 to ... [Read]
Biotechnology
Should You Be Investing in Biotech Stocks? Pain Therapeutics Up 150% and GT Biopharma Up Nearly 15%
What a way to start off the week! If you’re an investor, and you’re looking to spice up your investment portfolio, why not invest in some biotech stocks? Considering the industry has been doing quite ... [Read]
Biotechnology
Should you Buy Codexis Despite Lofty Valuations?
Codexis Inc. (NASDAQ:CDXS) has stunned investors with the massive growth of 68% in the last twelve months, soaring significantly by 213% in the last five years. CDXS stock is currently trading around $8.5 a share, ... [Read]
Biotechnology
Axovant Sciences Ltd. Shares Have Dropped Over 50% Today, Here’s Why.
Switzerland-based Axovant Sciences Ltd (NASDAQ:AXON) shares have plummeted over 50% today as it announces it has scrapped its program and experiments for curing a type of dementia. The drug was called intrepirdine and it has ... [Read]
Biotechnology
Ohr Pharmaceutical Experiences Disappointing 80% Drop in Stock After Reporting Even More Disappointing Test Results
Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) disappoints this week, the stock dropping over 80% – a complete one-eighty from many other biotech companies that have been soaring this week. Ohr Pharmaceutical stock experienced a drop of $1.6462, ... [Read]
Biotechnology
TiGenix to be Acquired by Takeda Pharmaceutical, Stocks Soars by 70%
TiGenix (NASDAQ:TIG) has joined the ranks of the biotech companies seeing stocks soar this week. The company is a biopharmaceutical company that exploits anti-inflammatory properties of stem cells to develop therapies for serious medical conditions ... [Read]
Biotechnology
Another Successful Healthcare Company: ChemoCentryx, Up 35%
The stock for ChemoCentryx Inc. (NASDAQ:CCXI) is on the rise, in the form of a 35% increase. This is only some of the good news for the company, which has just received two massive milestone ... [Read]
Biotechnology
Biotechnology Stocks On The Rise, Ampliphi Biosciences Corp Makes A 16% Rally After Clinical Treatment Success
Biotechnology stocks are doing extremely well on the exchanges today, as a few biotech companies around the world announced clinical trial successes this morning. AmpliPhi Biosciences Corp. (AMX:APHB) has shown a large rally, as the ... [Read]
Biotechnology
Successful Stem Cell Breakthrough Launches Cellect Biotechnology Ltd Stock Up Nearly 50%
Cellect Biotechnology Ltd. (NASDAQ:APOP) is having a great start on the trading floor this morning after announcing the breakthrough results of its clinical stem cell trial. The Israeli based company has stated that it has ... [Read]
Biotechnology
Spark Therapeutics Prices Genetic Treatment at $850,000 and Stock Still Managed to Climb
Spark Therapeutics Inc. (NASDAQ:ONCE) has finally released the price of its much-anticipated gene-therapy treatment for a rare form of genetic blindness and, while the price is lower than originally expected, it’s still a mighty steep ... [Read]